ATHENS, Ga., Sept. 17, 2009 (GLOBE NEWSWIRE) -- ArunA Biomedical, Inc., today announced that its Board of Directors has engaged RiversEdge BioVentures to evaluate strategic alternatives for the stem cell tools company. This will include the evaluation of potential fundraising opportunities, expansion of its strategic partnerships and potential combinations with strategic and financial investors.
RiversEdge BioVentures LLC is a private firm formed by David A. Dodd to provide advisory and investment services to life science companies. Prior to recently forming RiversEdge Bioventures Mr. Dodd achieved a distinguished career, serving in executive positions in several major pharmaceutical and life sciences companies.
ArunA is a privately held early stage biotechnology corporation dedicated to advancing drug discovery and basic research through the development and commercialization of innovative products and services derived from human stem cells.
Contact:
Aruna Biomedical, Inc. Press: Bud Ingalls, Chief Executive Officer 706-542-4941 bingalls@arunabiomedical.com RiversEdge BioVentures LLC Press: Kathryn Gallagher, Director Operations & Marketing 843-576-9840 k.gallagher@riversedgebioventures.com
